We are planning to raise Rs. 504 crore via IPO: Vikram Shah, Shalby Ltd.


Shalby Limited, one of the leading multi-speciality chain of hospitals in India, offers specialized healthcare services ranging from orthopaedics, complex joint replacements, cardiology, neurology, oncology and renal transplantations. Headquartered out of Ahmedabad, Shalby Limited currently operates a chain of 11 multi-specialty hospitals across India.

Yash Ved of Newsbarons provides you the highlights of a media interaction, where Vikram Shah, CMD, Shalby Limited informed “The company services through 11 operational hospitals with an aggregate bed capacity of 2012 beds”

NB: Brief us about your IPO plans?

Vikram Shah: We are planning to raise Rs. 500 crore via IPO. The IPO constitute of equity shares of face value of Rs. 10 each for cash at a price including a share premium on Tuesday, December 5, 2017.

NB: The IPO closes on Thursday, December 7, 2017.

Vikram Shah: The price band for the offer is fixed from Rs. 245 to Rs. 248per equity share.
Edelweiss Financial Services Ltd, IDFC Bank Ltd and IIFL Holdings Ltd are the book running lead managers to the issue.

NB: What are the objects of the issue?

Vikram Shah: The Proceeds of the initial public offer (IPO) will be utilised towards repayment of certain borrowings availed by the company, purchasing of medical equipment for existing, recently set-up as well as upcoming hospitals, purchase of interiors and allied infrastructure for upcoming hospitals and general corporate purposes.

NB: What will be the promoter holding post IPO?

Vikram Shah: Post IPO, the promoter holding would be 82%. Currently, the promoter holding stands at 99%.

NB: What is your total bed capacity?

Vikram Shah: The company services through 11 operational hospitals with an aggregate capacity of 2012 beds. We will be expanding into Vadodara and Nasik.

Its international footprint consists of five Outpatient Clinics and one SACE in Africa and two SACE in UAE.

NB: What is your market share in joint replacement surgeries?

Vikram Shah: We have 15% market share in joint replacement surgeries.

NB: What is your business strategy?

Vikram Shah: We will continue to strengthen hospital presence in Western and central India and expand into newer geographies. We will also continue to expand outreach programmes and to strengthen healthcare services across other specialities.